Cantor Fitzgerald has started coverage on Innoviva (INVA, Financial) with an Overweight rating, setting a price target of $26. This new rating indicates Cantor Fitzgerald's positive outlook on the company's future performance, suggesting that the stock could outperform its sector or the overall market. Innoviva's stock is under the spotlight as investors consider this fresh analyst perspective.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Innoviva Inc (INVA, Financial) is $55.00 with a high estimate of $55.00 and a low estimate of $55.00. The average target implies an upside of 188.56% from the current price of $19.06. More detailed estimate data can be found on the Innoviva Inc (INVA) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Innoviva Inc's (INVA, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Innoviva Inc (INVA, Financial) in one year is $23.57, suggesting a upside of 23.66% from the current price of $19.06. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Innoviva Inc (INVA) Summary page.
